Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease

• Christoph H Saely,
• Axel Muendlein,
• Alexander Vonbank,
• Heinz Drexel,
• Lukas Sprenger,
• Arthur Mader,
• Barbara Larcher,
• Maximilian Mächler,
• Daniela Zanolin-Purin,
• Andreas Leiherer

Affiliations

Christoph H Saely

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Axel Muendlein

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Alexander Vonbank

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Heinz Drexel

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Lukas Sprenger

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Arthur Mader

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Barbara Larcher

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Maximilian Mächler

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Daniela Zanolin-Purin

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria

Andreas Leiherer

VIVIT, Vorarlberg Institute of Vascular Investigation and Treatment, Feldkirch, Vorarlberg, Austria